The prevalence and prognostic and clinicopathological value of PD-L1 and PD-L2 in renal cell carcinoma patients: a systematic review and meta-analysis involving 3,389 patients

BACKGROUND: The research of the prognostic and clinicopathologic values of programmed cell death ligand 1/2 (PD-L1/2) in renal cell carcinoma (RCC) patients has been mired by a dearth of studies and considerable controversy. We thus conducted a systematic review and meta-analysis to report the preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yi, Song, Yuxuan, Xu, Yawei, Ou, Ningjing, Liang, Zhen, Hu, Rui, Zhang, Wei, Kang, Jiaqi, Wang, Xianhao, Liu, Li, Yang, Yongjiao, Liu, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215048/
https://www.ncbi.nlm.nih.gov/pubmed/32420142
http://dx.doi.org/10.21037/tau.2020.01.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215048/
https://www.ncbi.nlm.nih.gov/pubmed/32420142
http://dx.doi.org/10.21037/tau.2020.01.21

Ejemplares similares